What Is RPM In Health Overrated

Remote patient monitoring (RPM) is not a magic cure; its value is real but often overstated. Since the pandemic began, RPM use has jumped roughly 300 per cent, driving headlines and big promises for the future of care.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

1. What is RPM and why the buzz?

In plain terms, RPM means clinicians can watch a patient’s vital signs, activity levels or medication adherence from a distance, using sensors, apps or wearables. The tech promises faster interventions, fewer hospital trips and a more personalised health journey.

When I first covered the rollout of telehealth in 2020, I saw the same excitement. The hype was fuelled by two things:

• Speed of adoption: Hospitals rushed to digitise to keep doors open during lockdowns.
• Policy support: Medicare added temporary rebates for telehealth and, later, for RPM-related services.

From my experience around the country, the buzz was strongest in regional NSW, where remote monitoring could mean the difference between a 2-hour drive to a clinic or a quick check via a tablet.

But buzz alone does not equal benefit. To separate hype from hard outcomes, we need to look at the data.

2. RPM adoption: the numbers behind the hype

The RPM market is expanding fast. Home Healthcare Market Size to Hit USD 1,556.59 Billion by 2035 projects a multi-billion-dollar surge, driven largely by RPM devices. While the report focuses on global figures, the Australian share mirrors the global trend - clinicians are ordering more Bluetooth oximeters, glucose monitors and blood pressure cuffs than ever before.

Below is a snapshot of RPM adoption in Australia, based on Medicare item statistics and industry surveys:

The table shows a clear upward trajectory, with a threefold jump between 2019 and 2020 - the first year of COVID-19 restrictions. The growth slowed a bit after 2021, but the numbers remain far higher than pre-pandemic levels.

Why the surge?

1. Hospital capacity pressure: To free beds, clinicians shifted routine vitals checks to home.
2. Patient safety: Elderly patients with chronic heart disease could be flagged early for deterioration.
3. Reimbursement changes: Medicare added item 93922 for RPM, encouraging uptake.

Even with this growth, the technology is unevenly distributed. Rural Queensland clinics report higher RPM uptake than inner-city Sydney practices, where face-to-face appointments returned quickly after lockdowns.

Key Takeaways

• RPM use grew over threefold in Australia since 2019.
• Medicare rebates are a primary driver of adoption.
• Rural areas see higher RPM penetration than metro centres.
• Growth has slowed but remains above pre-pandemic levels.
• Benefits must be weighed against data quality and equity issues.

3. The promised benefits vs on-the-ground reality

Industry white papers tout four headline benefits: earlier detection, reduced admissions, lower costs and higher patient satisfaction. In practice, the picture is more nuanced.

When I visited a community health centre in Victoria, staff praised the ability to spot a falling SpO2 reading before a COPD flare. That’s a genuine win. However, they also flagged three recurring pain points:

• Data overload: Nurses spend an extra 15-20 minutes each shift reviewing dashboards that flag false-positives.
• Device reliability: Bluetooth connectivity failures meant some patients missed whole days of monitoring.
• Patient digital literacy: Older patients struggled to pair devices, leading to missed readings and frustration.

Research from the Australian Institute of Health and Welfare (AIHW) shows that while RPM can cut readmission rates for heart failure by up to 12 per cent, the effect is strongest when combined with a structured care programme and regular clinician contact.

That aligns with the Patient Care, Policy & More: A Look at This Year’s Virtual Care Trends notes that without clear workflow integration, RPM adds administrative burden rather than saving time.

In short, RPM works best when it is part of a broader, well-designed chronic-care pathway, not a standalone gadget.

Below are the main categories where RPM delivers (or fails to deliver) on its promises:

1. Clinical outcomes: Early detection is real, but only for conditions with clear numeric thresholds (e.g., blood pressure, glucose).
2. Cost savings: Savings appear after the first year, once devices are amortised and staff time stabilises.
3. Patient experience: Many enjoy the convenience, yet a minority feel monitored constantly and lose trust.
4. Equity: Patients without reliable internet or smartphones are left out, widening the digital divide.

4. When does RPM become overrated? A critical look

Here’s the thing: the hype around RPM sometimes obscures its limitations. I’ve seen three common myths that inflate expectations.

• Myth 1 - RPM replaces doctors. In reality, clinicians still need to interpret data, triage alerts and make decisions. RPM is a tool, not a substitute.
• Myth 2 - All patients benefit equally. Data shows that low-income or older cohorts often lack the devices or skills needed for reliable monitoring.
• Myth 3 - RPM automatically cuts costs. Implementation costs (devices, training, IT support) can be substantial. Without careful budgeting, savings may never materialise.

Another pitfall is regulatory uncertainty. UnitedHealthcare’s recent decision to drop prior authorisation for most paediatric services highlights how insurers can shift policies quickly (UnitedHealthcare Ends Prior Authorization for Most Pediatric Care). While that move is US-centric, it signals that reimbursement frameworks can change, leaving providers vulnerable.

From my own reporting, the biggest red flag is when RPM programmes are rolled out without clear metrics for success. A clinic in South Australia installed 200 Bluetooth blood pressure cuffs, but after six months there was no measurable reduction in hypertension-related admissions. The reason? No protocol for acting on out-of-range readings.

Bottom line: RPM is powerful when paired with clear clinical pathways, robust data governance and equitable access. Otherwise, it risks becoming a flashy add-on that drains resources.

5. What the future may hold for RPM in Australian health

Looking ahead, the trajectory of RPM will be shaped by three forces: policy, technology and consumer expectations.

1. Policy reforms: The Australian Government’s 2024 Digital Health Strategy earmarks AU$150 million for remote monitoring pilots, with a focus on Indigenous communities.
2. Tech advances: Next-generation sensors can now stream ECG data and detect arrhythmias without a chest strap, widening the range of conditions that can be remotely tracked.
3. Consumer demand: Patients who experienced telehealth during COVID expect continuity of digital care, and a survey by the Australian Digital Health Agency found 68 per cent would choose a provider that offers RPM.

To avoid the pitfalls I described earlier, providers should adopt a staged rollout:

• Phase 1 - Pilot with clear KPIs: Define what success looks like (e.g., 10% reduction in readmissions).
• Phase 2 - Integrate with EMR: Ensure data flows automatically into clinicians’ workflows.
• Phase 3 - Scale with equity safeguards: Provide subsidised devices for low-income patients and offer training sessions.

In my experience, the clinics that follow this disciplined approach see the biggest return on investment. One multi-site GP group in Perth reported a 15 per cent drop in emergency visits after a 12-month RPM programme, after tightening their alert thresholds and providing a community-based tech support line.

So, is RPM overrated? The answer is nuanced. It is overrated when sold as a universal fix, but undervalued when deployed thoughtfully. The challenge for Australian health is to harness the genuine benefits while keeping the hype in check.

FAQ

Q: What does RPM stand for in health?

A: RPM means remote patient monitoring - technology that lets clinicians track health data from a patient’s home in real time.

Q: How does Medicare reimburse RPM services?

A: Since 2020 Medicare has listed item 93922 for RPM, covering device costs and clinician time when a patient meets eligibility criteria, such as having a chronic condition.

Q: Is RPM effective for all chronic diseases?

A: It works best for conditions with measurable metrics - diabetes, hypertension and heart failure. For ailments without clear numeric signs, the benefit is limited.

Q: What are the main challenges of implementing RPM?

A: Common hurdles include data overload for clinicians, device connectivity issues, patient digital literacy gaps, and the upfront cost of equipment and training.

Q: Will RPM replace face-to-face visits?

A: No. RPM is a complement, not a substitute. It can reduce the frequency of in-person appointments but does not eliminate the need for physical examinations.